We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAC.WS
1076
CALL
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$7.36M 0.01%
750,363
VPCB
1077
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$7.35M 0.01%
749,984
PEPL
1078
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$7.34M 0.01%
748,549
FLD
1079
Fold Holdings
FLD
$22.9M
$7.33M 0.01%
+749,998
New +$7.32M
FOXO
1080
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$7.32M 0.01%
3,703
FVT
1081
DELISTED
Fortress Value Acquisition Corp. III
FVT
$7.31M 0.01%
741,986
MERC icon
1082
Mercer International
MERC
$44.7M
$7.29M 0.01%
522,564
+372,960
+249% +$4.8M
ALEC icon
1083
Alector
ALEC
$168M
$7.28M 0.01%
511,140
-569,714
-53% -$9.01M
SAMA
1084
DELISTED
Schultze Special Purpose Acquisition Corp. II Class A Common Stock
SAMA
$7.28M 0.01%
741,526
VTLE
1085
DELISTED
Vital Energy
VTLE
$7.27M 0.01%
+91,903
New +$6.67M
UAA icon
1086
Under Armour
UAA
$3.02B
$7.26M 0.01%
+426,729
New +$7.65M
TGR.U
1087
DELISTED
Kimbell Tiger Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TGR.U
$7.26M 0.01%
+716,849
New +$7.22M
MLTX icon
1088
MoonLake Immunotherapeutics
MLTX
$1.66B
$7.26M 0.01%
653,872
+120,968
+23% +$1.2M
SMH icon
1089
VanEck Semiconductor ETF
SMH
$66.1B
$7.26M 0.01%
53,800
-60,928
-53% -$8.34M
TCOA
1090
DELISTED
Zalatoris Acquisition Corp.
TCOA
$7.25M 0.01%
+742,500
New +$7.26M
GATEW
1091
CALL
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$7.24M 0.01%
734,998
ZINGW
1092
CALL
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$7.24M 0.01%
+735,000
New +$335K
GWII
1093
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
$7.23M 0.01%
734,151
EWZ icon
1094
PUT
iShares MSCI Brazil ETF
EWZ
$9.08B
$7.23M 0.01%
+191,200
New +$6.18M
AWK icon
1095
American Water Works
AWK
$26.3B
$7.22M 0.01%
43,615
+40,046
+1,122% +$6.35M
CIB icon
1096
Grupo Cibest SA
CIB
$20.9B
$7.21M 0.01%
169,129
+168,081
+16,038% +$6.06M
ASAX
1097
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$7.21M 0.01%
738,347
ARCK
1098
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
$7.2M 0.01%
718,983
+267,426
+59% +$2.68M
GS icon
1099
PUT
Goldman Sachs
GS
$309B
$7.2M 0.01%
21,800
+21,000
+2,625% +$7.42M
JAQC
1100
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
$7.19M 0.01%
746,578

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.